The existing research indicates that the presence of ERα does not affect survivability [16, 65], nor it is associated with a poor prognosis [66], notably when linked with absence of ERβ [56] or EGFR disturbances, especially in Japanese patients with adenocarcinoma [56, 68, 74]. This evidence concerns the gene ESR2 and adenocarcinoma.